News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–22
Matches
22
Sources here
10
Companies here
5
Search results Stored financial headlines

Active search

22 matching headlines

Ticker or company: MOONMain company stories
Clear
Latest

Stock Titan Deals and strategy

Cormorant Asset Management (MLTX) discloses 4.35% MoonLake Immunotherapeutics stake

Cormorant Asset Management, LP and Bihua Chen have disclosed a 4.35% beneficial ownership stake in MoonLake Immunotherapeutics (MLTX), totaling 3,205,433 Class A ordinary shares. This stake, reported via a SCHEDULE 13G/A filing, indicates shared voting and dispositive power over the shares and is based on 73,615,396 Class A ordinary shares outstanding as of May 1, 2026. The filing …

Main company 🇺🇸 United States
Read at Stock Titan
Sharemaestro market context Trend signal active 52 weeks -70.5% MLTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
Stock Titan Deals and strategy Main company 🇺🇸 United States

Deep Track reports 7.99M-share, 9.74% stake in MoonLake (MLTX) in 13G/A

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have filed an amended Schedule 13G/A, reporting a collective beneficial ownership of 7,999,025 Class A ordinary shares, representing a 9.74% stake in MoonLake Immunotherapeutics (MLTX). This ownership includes 1,000,000 Pre-Funded Warrants, …

MLTX main company
Sharemaestro market context Trend signal active 52 weeks -70.5% MLTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Sahm Earnings Main company 🇺🇸 United States

MoonLake’s Psoriatic Arthritis Drug Shows Promise In Late-Stage Study

MoonLake Immunotherapeutics announced positive Week 16 topline results from its Phase 3 IZAR-1 trial for sonelokimab in biologic-naïve adults with active psoriatic arthritis, meeting all primary and secondary clinical endpoints. Despite the positive results, the stock fell over 6%. The company also reported strong …

MLTX main company
Sharemaestro market context Trend signal active 52 weeks -70.5% MLTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Bitget Market update Main company 🇺🇸 United States

MoonLake Immunotherapeutics CSO Kristian Reich disposes of $1 million in common shares

Kristian Reich, Chief Scientific Officer of MoonLake Immunotherapeutics, sold 52,448 Class A ordinary shares totaling approximately $1 million on July 21-22. The shares were sold at prices of $20.02 and $20 per share. Following these transactions, his indirect holdings decreased to 2,712,298 shares, while …

MLTX main company
Sharemaestro market context Trend signal active 52 weeks -70.5% MLTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Jerucon plans 150,000-share MLTX sale in Form 144 (Nasdaq: MLTX)

Jerucon Beratungsgesellschaft mbH has filed a Form 144 notice to sell 150,000 Class A Ordinary shares of MoonLake Immunotherapeutics (MLTX) through UBS Financial Services, Inc. on or after July 15, 2026, for an aggregate value of $2,916,000. This filing also reports previous sales by …

MLTX main company
Sharemaestro market context Trend signal active 52 weeks -70.5% MLTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

MoonLake Immunotherapeutics (NASDAQ: MLTX) raises $30M via option exercise

MoonLake Immunotherapeutics announced that underwriters fully exercised their option to purchase an additional 1,500,000 Class A ordinary shares as part of a previously announced public offering. This exercise, which closed on July 14, 2026, generated an additional $30.0 million in gross proceeds for the …

MLTX main company
Sharemaestro market context Trend signal active 52 weeks -70.5% MLTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context